Advancing Access to Innovative Medicines in Africa: Clinical Trials Take Centre Stage

As Africa continues to build resilient healthcare systems, expanding access to innovative medicines remains a top priority. A major step forward is now underway with new clinical trials being launched across the continent — aimed at ensuring that lifesaving treatments are developed, tested, and made accessible with African patients in mind.

Historically, most clinical trials have taken place outside of Africa, limiting the continent’s access to cutting-edge therapies and resulting in treatments that may not always reflect the unique healthcare needs of African populations. This imbalance is now being addressed through a growing push for African-led and Africa-based research, driven by public-private partnerships and regional health organisations.

These clinical trials are not only essential for ensuring safe and effective treatments for African communities, but also for building local capacity in research, regulation, and healthcare delivery. By strengthening clinical trial infrastructure, African countries are better positioned to attract global pharmaceutical investment, accelerate drug approvals, and ultimately improve health outcomes across the region.

At Pharma West Africa, we recognise the vital role that innovation and clinical research play in shaping the future of healthcare. Our platform brings together stakeholders from across the pharmaceutical supply chain – from international manufacturers and national regulatory authorities to researchers and distributors – to foster partnerships, share insights, and support the development of a more self-reliant and inclusive healthcare ecosystem in West Africa.

Explore how your business can contribute to and benefit from Africa’s evolving pharmaceutical landscape. Join us at Pharma West Africa 2026 to be part of the conversation and the solution.